Merck Sharp and Dohme Corp. v. Hospira, Inc.
Merck Sharp and Dohme Corp. v. Hospira, Inc., 17-1115
Affirming the district court’s determination that patents relating to aspects of the production of an antibiotic compound were obvious implementations of disclosures made in other patents that would constitute nothing more than the routine way a skilled artisan would apply the patent’s teachings.
- Published 2017/10/26
- United States Federal Circuit